Skip to content

Clinical trials

Phase 2 Ischemic Stroke trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Ischemic Stroke Phase: Phase 2 Country / region: South Korea Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20121
20141
20166
20181
20192
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed9
Unknown status3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shin Poong Pharmaceutical Co. Ltd.2
AbbVie1
Asan Medical Center1
Bristol-Myers Squibb1
GNT Pharma1
Hocheol Kim1
Jeil Pharmaceutical Co., Ltd.1
Jong Sung Kim1
Pfizer1
Seoul National University Bundang Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Ischemic Stroke14
Ischemic Attack, Transient2
Cerebral Infarction1
Hypertension1
Intracranial Hemorrhages1
Stroke1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.